IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $750,572 | +32.3% | 16,547 | +10.2% | 0.09% | -33.8% |
| Q4 2022 | $567,230 | +35.7% | 15,018 | +32.9% | 0.14% | +21.4% |
| Q2 2022 | $418,000 | -20.8% | 11,299 | -34.9% | 0.11% | -38.1% |
| Q4 2021 | $528,000 | -20.8% | 17,346 | -12.8% | 0.18% | -16.6% |
| Q3 2021 | $667,000 | -32.3% | 19,896 | +22.0% | 0.22% | -28.1% |
| Q4 2019 | $985,000 | +169.9% | 16,311 | +187.1% | 0.30% | +81.9% |
| Q2 2019 | $365,000 | +18.5% | 5,681 | -6.2% | 0.17% | -42.0% |
| Q2 2017 | $308,000 | – | 6,059 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |